Poxel Presents New Preclinical Imeglimin Data on Improvement in Diastolic Function at the American Diabetes Association Meeting Jun 12, 2017
Poxel Announces Additional Positive Results for Imeglimin Phase 2b Study in Japan for the Treatment of Type 2 Diabetes Jun 6, 2017
Poxel to Present New Preclinical Imeglimin Data on Protective Benefits from Diabetic Cardiomyopathy at the American Diabetes Association Meeting May 30, 2017
Poxel Presents Imeglimin Japanese Phase 1 Results and Mechanistic Data at the 9th Scientific Meeting of the Asian Association for the Study of Diabetes in Japan May 22, 2017
Poxel Announces Positive Top Line Results for Imeglimin Phase 2b Study in Japan for the Treatment of Type 2 Diabetes May 4, 2017
